Haarzellleukämie = ResterkrankungHairy cell leukemia
Hairy cell leukemia was initially described as a distinct entity in 1958. It is rare B-cell malignancy characterized by an indolent course. Advances in the treatment and understanding of the biology of hairy cell leukemia have made the disease exquisitely amenable to treatment. This review summarize...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | German English |
| Published: |
20. März 2015
|
| In: |
Der Internist
Year: 2015, Volume: 56, Issue: 4, Pages: 381-390 |
| ISSN: | 1432-1289 |
| DOI: | 10.1007/s00108-014-3599-2 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1007/s00108-014-3599-2 Verlag, Volltext: https://link.springer.com/article/10.1007/s00108-014-3599-2 
|
| Author Notes: | S. Dietrich, M. Andrulis, T. Zenz |
| Summary: | Hairy cell leukemia was initially described as a distinct entity in 1958. It is rare B-cell malignancy characterized by an indolent course. Advances in the treatment and understanding of the biology of hairy cell leukemia have made the disease exquisitely amenable to treatment. This review summarizes the present understanding of hairy cell leukemia with a particular focus on the development of novel and targeted approaches to treatment. |
|---|---|
| Item Description: | Gesehen am 21.07.2017 |
| Physical Description: | Online Resource |
| ISSN: | 1432-1289 |
| DOI: | 10.1007/s00108-014-3599-2 |